Synthesis process method of pesticide flubendiamide

Through two-step reaction and metal palladium catalyst, the synthesis of bromobilizide is simplified, and the problems of cumbersome operation and harsh reaction conditions in the existing technology are solved, and efficient and simple bromobilizide synthesis is achieved. , suitable for industrial production.

CN119059926APending Publication Date: 2024-12-03JUNKAI (TIANJIN) CHEM CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411363386.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-27
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

The existing synthesis method of bromobis fluorobenzodiamide has problems such as cumbersome operation, harsh reaction conditions, long reaction time, column chromatography purification and long routes, which leads to unsuitable for industrial production.

Method used

The metal palladium catalyst was used to directly and efficiently synthesize the bromobilibisamide through two-step reaction, simplifying the operation, reducing the reaction conditions, reducing the steps, using protective gas and autoclave for reaction, and obtaining the target product by filtration and recrystallization.

Benefits of technology

It has achieved efficient synthesis of bromobis fluorobenzobisamide, which is easy to operate, suitable reaction conditions and good overall yield, laying the foundation for industrial production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119059926A_ABST
    Figure CN119059926A_ABST
Patent Text Reader

Abstract

The invention provides a synthesis process method of pesticide flubendiamide, which comprises the following steps: S1, sequentially adding a metal palladium catalyst, a ligand and an organic solvent into a high-pressure kettle, stirring, sequentially adding alkali, iodobenzene and 3-bromine-2-fluoro-N-methylaniline into the high-pressure kettle, raising the pressure, raising the temperature, stirring for reaction, and cooling to room temperature; the obtained organic solution of N-(3-bromo-2-fluorophenyl)-N-methylbenzamide is directly used for the next step at the nuclear magnetic internal standard yield; s2, sequentially adding an organic solution of N-(3-bromine-2-fluorophenyl)-N-methyl benzamide, a metal palladium catalyst, a ligand, alkali and 2-bromine-4-(perfluoropropyl-2-yl)-6-(trifluoromethyl) aniline into a high-pressure kettle, increasing the pressure, heating, stirring and reacting, concentrating under reduced pressure to recover a solvent, and recrystallizing to obtain a product. The target product is efficiently synthesized through continuous two-step reaction by using the metal palladium catalyst for catalysis, the total yield is good, the operation is simple and convenient, the route is short, the reaction conditions are not harsh, and a foundation is laid for further pilot scale production.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of organic synthesis, and in particular relates to a synthetic process method of the pesticide bromofenac. Background Art

[0002] Brofenac is a diamide insecticide with a novel mechanism of action jointly developed by Mitsui Agrochemicals, Ltd. and BASF. It can effectively solve the problem of pest resistance to other insecticides such as chlorfenac and fipronil. It has significant activity against a variety of resistant target pests such as Lepidoptera and Coleoptera, especially against larval stage pests. In addition, brofenac can also be used as a seed treatment agent, and has good killing activity against termites, ants, cockroaches and flies, etc. It is mainly used for the prevention and control of pests of crops and non-crops such as rice, beans and vegetables.

[0003] At present, the synthesis method of bromofenac is mainly:

[0004] 1. Using 2-chloro-3-nitrobenzoic acid as the starting material, 2-fluoro-3-(N-methylbenzoyl)aminobenzoic acid methyl ester is obtained through acid esterification, chlorofluorination, nitro reduction, aminoformaldehyde condensation reduction methylation, and benzoylation, and then the ester is hydrolyzed into acid, acid chlorinated, and amidated with 2-bromo-4(perfluoropropane-2-yl)-6-trifluoromethylaniline to obtain bromofenac in a total of 8 steps.

[0005] 2. Using 2-chloro-3-nitrobenzoic acid as the starting material, bromofenac was obtained through six steps: acid chlorination, amidation with 2-bromo-4-(perfluoropropane-2-yl)-6-trifluoromethyl)aniline, chlorination, nitro reduction, aminoformaldehyde condensation reduction methylation, and benzoylation.

[0006] 3. Using 2-fluoro-3-nitrobenzoic acid as the starting material, after chlorination, amidation with 2-bromo-6-iodo-4-(perfluoropropane-2-yl)aniline, and alkylation with trifluoromethyltrimethylsilane, nitro reduction, N-methylation, and benzamidation, bromofenac is obtained in 6 steps.

[0007] The current synthesis method of bromofenac has the following problems: a. Some steps require recycling of raw materials for repeated use, resulting in cumbersome operations; b. Some steps have harsh reaction conditions (such as reaction at -70°C) and long reaction times; c. Some steps require column chromatography for purification and separation, and are therefore not suitable for industrial production; d. The overall route is long, requiring 6-8 steps of reaction. Summary of the invention

[0008] In view of this, the present invention aims to provide a synthetic process method for the pesticide insecticide bromofenac, which is simple to operate, and can efficiently synthesize the target product in two steps with good yield.

[0009] To achieve the above object, the technical solution of the present invention is achieved as follows:

[0010] A synthetic process for the pesticide bromofenac, comprising the following steps:

[0011] S1: under protective gas, a metal palladium catalyst, a ligand and an organic solvent are sequentially added to an autoclave, and after stirring for 1 hour, a base, iodobenzene and 3-bromo-2-fluoro-N-methylaniline are sequentially added to the autoclave, and carbon monoxide gas is then introduced into the autoclave to increase the pressure, and the temperature is raised and stirred until the reaction is complete, and the insoluble matter is filtered to remove the organic solution of N-(3-bromo-2-fluorophenyl)-N-methylbenzamide, which is directly used in the next step according to the NMR internal standard yield;

[0012] S2: Under protective gas, the organic solution of N-(3-bromo-2-fluorophenyl)-N-methylbenzamide obtained in S1, a metal palladium catalyst, a ligand, a base and 2-bromo-4-(perfluoropropan-2-yl)-6-(trifluoromethyl)aniline are added successively into an autoclave, carbon monoxide gas is then introduced into the autoclave to increase the pressure, the temperature is raised and stirred until the reaction is complete, the insoluble matter is filtered out, the solvent is recovered by concentration under reduced pressure, and the product bromofenac is obtained by recrystallization.

[0013] Furthermore, the molar ratio of the metal palladium catalyst, the ligand, the base, iodobenzene, and 3-bromo-2-fluoro-N-methylaniline in S1 is (0.01-0.05): (0.01-0.1): (1-2): 1: (1-2);

[0014] The molar ratio of the metal palladium catalyst, ligand, base, N-(3-bromo-2-fluorophenyl)-N-methylbenzamide and 2-bromo-4-(perfluoropropan-2-yl)-6-(trifluoromethyl)aniline in S2 is (0.02-0.1):(0.02-0.2):(1-2):1:(1-2).

[0015] Furthermore, the molar ratio of the metal palladium catalyst, the ligand, the base, iodobenzene and 3-bromo-2-fluoro-N-methylaniline in S1 is 0.03:0.03:1.5:1:1.5.

[0016] Furthermore, the molar ratio of the metal palladium catalyst, ligand, base, N-(3-bromo-2-fluorophenyl)-N-methylbenzamide, and 2-bromo-4-(perfluoropropan-2-yl)-6-(trifluoromethyl)aniline in S2 is 0.05:0.1:2:1:1.5.

[0017] Furthermore, the ratio of iodobenzene to organic solvent in S1 is 1 g: 5-10 mL;

[0018] Preferably, the usage ratio of iodobenzene to the organic solvent is 1 g:10 mL.

[0019] Furthermore, the metal palladium catalyst in S1 and S2 is one of palladium chloride and palladium acetate.

[0020] Furthermore, the ligands in S1 and S2 are one or more of triphenylphosphine, bis(diphenylphosphino)methane, and tricyclohexylphosphine.

[0021] Furthermore, the base in S1 and S2 is any one of triethylamine, diisopropylamine and tri-n-propylamine.

[0022] Furthermore, the organic solvent in S1 is one or more of toluene, N,N-dimethylformamide, and 1,4-dioxane.

[0023] Furthermore, the protective gas in S1 and S2 is an inert gas, and preferably, the inert gas is one of argon or nitrogen.

[0024] Furthermore, the pressure in S1 is increased to 1-2 MPa, and the reaction temperature during heating and stirring is 50-60°C.

[0025] Furthermore, the pressure in S2 is increased to 3-4 MPa, and the reaction temperature during heating and stirring is 95-105°C.

[0026] Compared with the prior art, the synthetic process of the pesticide bromofenac has the following advantages:

[0027] The method for synthesizing the pesticide bromofenac, described in the present invention, uses a metal palladium catalyst to directly and efficiently synthesize the target product through two consecutive steps of reaction with a good total yield. Compared with the existing synthetic routes, the route is simple to operate, the route is short, and the reaction conditions are not harsh, laying the foundation for further pilot production. BRIEF DESCRIPTION OF THE DRAWINGS

[0028] The accompanying drawings constituting a part of the present invention are used to provide a further understanding of the present invention. The exemplary embodiments of the present invention and their descriptions are used to explain the present invention and do not constitute an improper limitation of the present invention. In the accompanying drawings:

[0029] Figure 1 This is the HPLC chart of bromofenac described in Example 1 of the present invention. DETAILED DESCRIPTION

[0030] It should be noted that, in the absence of conflict, the embodiments of the present invention and the features in the embodiments may be combined with each other.

[0031] Unless otherwise defined, the technical terms used in the following examples have the same meanings as those generally understood by those skilled in the art to which the present invention belongs. The test reagents used in the following examples, unless otherwise specified, are all conventional biochemical reagents; the experimental methods, unless otherwise specified, are all conventional methods.

[0032] The present invention will be described in detail below with reference to the accompanying drawings and in conjunction with embodiments.

[0033] Example 1

[0034] S1: Under nitrogen protection, palladium chloride (26.6 mg, 0.15 mmol), bis(diphenylphosphino)methane (57.7 mg, 0.15 mmol) and 10 mL of toluene were added to the autoclave in sequence. After stirring for 1 h, triethylamine (758.9 mg, 7.5 mmol), iodobenzene (1020.1 mg, 5 mmol) and 3-bromo-2-fluoro-N-methylaniline (1530.3 mg, 7.5 mmol) were added to the autoclave in sequence. Carbon monoxide gas was then introduced into the autoclave to a pressure of 1.5 MPa, and then the temperature was raised to 55° C. and stirred until the reaction was complete. The insoluble matter was then filtered to remove the insoluble matter, and a toluene solution containing 1371.3 mg of N-(3-bromo-2-fluorophenyl)-N-methylbenzamide was obtained. The NMR internal standard yield was 89%, which was directly used in the next step.

[0035] S2: Under nitrogen protection, the toluene solution containing 1371.3 mg of N-(3-bromo-2-fluorophenyl)-N-methylbenzamide obtained in S1, palladium acetate (50.4 mg, 0.22 mmol), triphenylphosphine (116.7 mg, 0.45 mmol), diisopropylamine (900.6 mg, 8.9 mmol) and 2-bromo-4-(perfluoroprop-2-yl)-6-(trifluoromethyl)aniline (2723.7 mg, 6.68 mmol) were added into the autoclave in sequence, and then carbon monoxide gas was filled into the autoclave to increase the pressure to 3.5 MPa, and then the temperature was raised to 100°C and stirred until the reaction was complete. Subsequently, the insoluble matter was removed by filtration, and the toluene was recovered by concentration under reduced pressure. The product bromofenac 2.4 g was obtained by recrystallization from ethanol, with a yield of 83%.

[0036] Example 2

[0037] S1: Under nitrogen protection, palladium chloride (8.9 mg, 0.05 mmol), tricyclohexylphosphine (28 mg, 0.1 mmol) and 6 mL of N,N-dimethylformamide were added to the autoclave in sequence. After stirring for 1 h, triethylamine (506 mg, 5 mmol), iodobenzene (1020.1 mg, 5 mmol) and 3-bromo-2-fluoro-N-methylaniline (1020.2 mg, 5 mmol) were added to the autoclave in sequence. Carbon monoxide gas was then introduced into the autoclave to a pressure of 2 MPa, and then the temperature was raised to 60°C and stirred until the reaction was complete. The insoluble matter was then filtered to remove the insoluble matter, and an N,N-dimethylformamide solution containing 1109.3 mg of N-(3-bromo-2-fluorophenyl)-N-methylbenzamide was obtained. The NMR internal standard yield was 72%, which was directly used in the next step.

[0038] S2: Under nitrogen protection, the N,N-dimethylformamide solution containing 1109.3 mg of N-(3-bromo-2-fluorophenyl)-N-methylbenzamide obtained in S1, palladium acetate (81.5 mg, 0.36 mmol), triphenylphosphine (188.8 mg, 0.72 mmol), tri-n-propylamine (773.7 mg, 5.4 mmol) and 2-bromo-4-(perfluoroprop-2-yl)-6-(trifluoromethyl)aniline (2644.1 mg, 6.5 mmol) were added into the autoclave in sequence, and then carbon monoxide gas was filled into the autoclave to 4 MPa, and then the temperature was raised to 100°C and stirred until the reaction was complete. Subsequently, the insoluble matter was removed by filtration, and the N,N-dimethylformamide was recovered by concentration under reduced pressure. The product bromofenac was obtained by recrystallization from ethanol with a yield of 85%.

[0039] Example 3

[0040] S1: Under nitrogen protection, palladium acetate (56.6 mg, 0.25 mmol), bis(diphenylphosphino)methane (96.1 mg, 0.25 mmol) and 8 mL of 1,4-dioxane were added to the autoclave in sequence. After stirring for 1 h, diisopropylamine (1011.9 mg, 10 mmol), iodobenzene (1020.1 mg, 5 mmol) and 3-bromo-2-fluoro-N-methylaniline (2040.4 mg, 10 mmol) were added to the autoclave in sequence. Carbon monoxide gas was then introduced into the autoclave to a pressure of 1 MPa, and then the temperature was raised to 55°C and stirred until the reaction was complete. The insoluble matter was then filtered to remove the insoluble matter, and a 1,4-dioxane solution containing 1248 mg of N-(3-bromo-2-fluorophenyl)-N-methylbenzamide was obtained. The internal standard yield of NMR was 81%, which was directly used in the next step.

[0041] S2: Under nitrogen protection, the 1,4-dioxane solution containing 1248 mg of N-(3-bromo-2-fluorophenyl)-N-methylbenzamide obtained in S1, palladium acetate (18.3 mg, 0.08 mmol), tricyclohexylphosphine (45.4 mg, 0.16 mmol), triethylamine (414.9 mg, 4.1 mmol) and 2-bromo-4-(perfluoroprop-2-yl)-6-(trifluoromethyl)aniline (1263.4 mg, 4.1 mmol) were added into the autoclave in sequence, and then carbon monoxide gas was filled into the autoclave to 4 MPa, and then the temperature was raised to 105°C and stirred until the reaction was complete. Subsequently, the insoluble matter was removed by filtration, and the 1,4-dioxane was recovered by concentration under reduced pressure. The product bromofenac 1.85 g was obtained by recrystallization from ethanol, with a yield of 69%.

[0042] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principle of the present invention should be included in the protection scope of the present invention.

Claims

1. A synthetic process for the pesticide bromofenac, characterized in that: The following steps are involved: S1: under protective gas, a metal palladium catalyst, a ligand and an organic solvent are sequentially added to an autoclave, and after stirring, a base, iodobenzene and 3-bromo-2-fluoro-N-methylaniline are sequentially added to the autoclave, and carbon monoxide gas is then introduced into the autoclave to increase the pressure, the temperature is raised and stirred until the reaction is complete, and the insoluble matter is filtered to remove the organic solution of N-(3-bromo-2-fluorophenyl)-N-methylbenzamide, which is directly used in the next step according to the nuclear magnetic internal standard yield; S2: Under protective gas, the organic solution of N-(3-bromo-2-fluorophenyl)-N-methylbenzamide obtained in S1, a metal palladium catalyst, a ligand, a base and 2-bromo-4-(perfluoropropan-2-yl)-6-(trifluoromethyl)aniline are added successively into an autoclave, carbon monoxide gas is then introduced into the autoclave to increase the pressure, the temperature is raised and stirred until the reaction is complete, the insoluble matter is filtered out, the solvent is recovered by concentration under reduced pressure, and the product bromofenac is obtained by recrystallization.

2. The synthetic process of the pesticide insecticide bromofenac according to claim 1, characterized in that: The molar ratio of the metal palladium catalyst, the ligand, the base, iodobenzene and 3-bromo-2-fluoro-N-methylaniline in S1 is (0.01-0.05): (0.01-0.1): (1-2): 1: (1-2); The molar ratio of the metal palladium catalyst, ligand, base, N-(3-bromo-2-fluorophenyl)-N-methylbenzamide and 2-bromo-4-(perfluoropropan-2-yl)-6-(trifluoromethyl)aniline in S2 is (0.02-0.1):(0.02-0.2):(1-2):1:(1-2).

3. The synthetic process of the pesticide insecticide bromofenac according to claim 1, characterized in that: The dosage ratio of iodobenzene to organic solvent in S1 is 1 g: 5-10 mL; Preferably, the usage ratio of iodobenzene to the organic solvent is 1 g:10 mL.

4. The synthetic process of the pesticide insecticide bromofenac according to claim 1, characterized in that: The metal palladium catalyst in S1 and S2 is one of palladium chloride and palladium acetate.

5. The synthetic process of the pesticide insecticide bromofenac according to claim 1, characterized in that: The ligands in S1 and S2 are one or more of triphenylphosphine, bis(diphenylphosphino)methane, and tricyclohexylphosphine.

6. The synthetic process of the pesticide insecticide bromofenac according to claim 1, characterized in that: The base in S1 and S2 is any one of triethylamine, diisopropylamine and tri-n-propylamine.

7. The synthetic process of the pesticide insecticide bromofenac according to claim 1, characterized in that: The organic solvent in S1 is one or more of toluene, N,N-dimethylformamide, and 1,4-dioxane.

8. The synthetic process of the pesticide insecticide bromofenac according to claim 1, characterized in that: The protective gas in S1 and S2 is an inert gas, and preferably, the inert gas is one of argon or nitrogen.

9. The synthetic process of the pesticide insecticide bromofenac according to claim 1, characterized in that: The pressure in S1 is increased to 1-2 MPa, and the reaction temperature is increased to 50-60°C with stirring.

10. The synthetic process of the pesticide insecticide bromofenac according to claim 1, characterized in that: The pressure in S2 is increased to 3-4 MPa, and the reaction temperature is increased to 95-105°C with stirring.